THE OKLAHOMA-PITTSBURGH EXPERIENCE WITH INTERFERON-ALPHA IN THE TREATMENT OF HCV DISEASE

被引：0
|
作者：
VANTHIEL, DH
FRIEDLANDER, L
FAGIUOLI, S
MALLOY, P
WRIGHT, HI
SUBBOTIN, V
CARACENI, P
机构：
[1] W PENN HOSP, PITTSBURGH, PA USA
[2] UNIV PITTSBURGH, SCH MED, PITTSBURGH, PA 15213 USA
来源：
GASTROENTEROLOGY | 1994年 / 106卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1002 / A1002
页数：1
相关论文
共 50 条
  • [21] RT-PCR DRIVEN IN-SITU HYBRIDIZATION AND SERUM HCV RNA IN TREATMENT OF CHRONIC HCV LIVER-DISEASE WITH INTERFERON-ALPHA
    LAKEBAKAAR, G
    GALIZI, M
    LEE, TP
    NUOVO, G
    LANE, B
    GASTROENTEROLOGY, 1994, 106 (04) : A923 - A923
  • [22] A NOVEL ANTIVIRAL MECHANISM OF INTERFERON-ALPHA: INTERFERON-ALPHA INDUCED IFIT3 MEDIATES ANTI-HCV EFFECT
    Dou, Diana R.
    Zhang, Xiaozhen
    Kohli, Anita
    Kottilil, Shyam
    HEPATOLOGY, 2011, 54 : 1336A - 1337A
  • [23] Interferon-alpha 2a treatment for refractory Behcet's disease
    Lai, Yung Jen
    Chan, Wei-Chun
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2018, 8 (03) : 168 - 172
  • [24] Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia
    Russo, D
    Candoni, A
    Grattoni, R
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 : S47 - S49
  • [25] Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients
    Hadoux, Julien
    Terroir, Marie
    Leboulleux, Sophie
    Deschamps, Frederic
    Al Ghuzlan, Abir
    Hescot, Segolene
    Tselikas, Lambros
    Borget, Isabelle
    Caramella, Caroline
    Deandreis, Desiree
    Goere, Diane
    De Baere, Thierry
    Schlumberger, Martin
    Baudin, Eric
    HORMONES & CANCER, 2017, 8 (5-6): : 330 - 337
  • [26] Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients
    Julien Hadoux
    Marie Terroir
    Sophie Leboulleux
    Frederic Deschamps
    Abir Al Ghuzlan
    Ségolène Hescot
    Lambros Tselikas
    Isabelle Borget
    Caroline Caramella
    Desirée Déandréis
    Diane Goere
    Thierry De Baere
    Martin Schlumberger
    Eric Baudin
    Hormones and Cancer, 2017, 8 : 330 - 337
  • [27] Interferon-alpha 2a treatment of neuro-Behcet disease
    Nichols, JC
    Ince, A
    Akduman, L
    Mann, ES
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (02) : 109 - 111
  • [28] INFLUENCE OF INTERFERON-ALPHA AND URSODESOXYCHOLIC ACID ON ANTI-HCV IGM AND HCV RNA
    MOHLER, M
    TOX, U
    KALLINOWSKI, B
    THEILMANN, L
    GOESER, T
    HEPATOLOGY, 1994, 20 (04) : A169 - A169
  • [29] INTERFERON-ALPHA AND PSORIASIS - VARIATIONS IN SERUM INTERFERON-ALPHA CONCENTRATIONS DURING THE COURSE OF PSORIASIS-TREATMENT
    RUFFAULT, A
    PIBOUIN, M
    SANDRON, A
    DUVAIL, C
    HUGHES, L
    CHEVRANTBRETON, J
    FAUCONNIER, B
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1988, 115 (09): : 985 - 985
  • [30] Neutralizing antibody treatment against interferon-alpha in SCID mice with HIV encephalitis and interferon-alpha neurotoxicity
    Tyor, William
    Bimonte-Nelson, Heather
    Smothers, Corigan
    Woodward, John
    Sas, Andrew
    NEUROLOGY, 2008, 70 (11) : A251 - A251
12345